SRDX
Price
$29.39
Change
+$0.30 (+1.03%)
Updated
Jun 27, 01:22 PM (EDT)
Capitalization
397.04M
33 days until earnings call
VNRX
Price
$0.84
Change
-$0.03 (-3.45%)
Updated
Jun 27, 01:26 PM (EDT)
Capitalization
62.13M
47 days until earnings call
Interact to see
Advertisement

SRDX vs VNRX

Header iconSRDX vs VNRX Comparison
Open Charts SRDX vs VNRXBanner chart's image
Surmodics
Price$29.39
Change+$0.30 (+1.03%)
Volume$453
Capitalization397.04M
VolitionRX
Price$0.84
Change-$0.03 (-3.45%)
Volume$100
Capitalization62.13M
SRDX vs VNRX Comparison Chart in %
Loading...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRDX vs. VNRX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRDX is a Buy and VNRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (SRDX: $29.09 vs. VNRX: $0.87)
Brand notoriety: SRDX and VNRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SRDX: 66% vs. VNRX: 72%
Market capitalization -- SRDX: $397.04M vs. VNRX: $62.13M
SRDX [@Medical Specialties] is valued at $397.04M. VNRX’s [@Medical Specialties] market capitalization is $62.13M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRDX’s FA Score shows that 0 FA rating(s) are green whileVNRX’s FA Score has 0 green FA rating(s).

  • SRDX’s FA Score: 0 green, 5 red.
  • VNRX’s FA Score: 0 green, 5 red.
According to our system of comparison, VNRX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRDX’s TA Score shows that 6 TA indicator(s) are bullish while VNRX’s TA Score has 6 bullish TA indicator(s).

  • SRDX’s TA Score: 6 bullish, 3 bearish.
  • VNRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SRDX is a better buy in the short-term than VNRX.

Price Growth

SRDX (@Medical Specialties) experienced а -0.17% price change this week, while VNRX (@Medical Specialties) price change was +29.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.93%. For the same industry, the average monthly price growth was +1.22%, and the average quarterly price growth was -0.15%.

Reported Earning Dates

SRDX is expected to report earnings on Jul 30, 2025.

VNRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Medical Specialties (+0.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRDX($397M) has a higher market cap than VNRX($62.1M). VNRX YTD gains are higher at: 44.667 vs. SRDX (-26.540). SRDX has higher annual earnings (EBITDA): 22.1M vs. VNRX (-34.04M). SRDX has more cash in the bank: 35.2M vs. VNRX (20.7M). VNRX has less debt than SRDX: VNRX (5.86M) vs SRDX (33.9M). SRDX has higher revenues than VNRX: SRDX (138M) vs VNRX (775K).
SRDXVNRXSRDX / VNRX
Capitalization397M62.1M639%
EBITDA22.1M-34.04M-65%
Gain YTD-26.54044.667-59%
P/E Ratio71.51N/A-
Revenue138M775K17,806%
Total Cash35.2M20.7M170%
Total Debt33.9M5.86M579%
FUNDAMENTALS RATINGS
SRDX vs VNRX: Fundamental Ratings
SRDX
VNRX
OUTLOOK RATING
1..100
1123
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
6337
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VNRX's Valuation (50) in the Medical Or Nursing Services industry is somewhat better than the same rating for SRDX (92) in the Medical Specialties industry. This means that VNRX’s stock grew somewhat faster than SRDX’s over the last 12 months.

VNRX's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as SRDX (100) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's SMR Rating (93) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that SRDX’s stock grew similarly to VNRX’s over the last 12 months.

VNRX's Price Growth Rating (37) in the Medical Or Nursing Services industry is in the same range as SRDX (63) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that SRDX’s stock grew similarly to VNRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRDXVNRX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 12 days ago
67%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 19 days ago
68%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBIX6.57N/A
N/A
AB Relative Value I
MTRIX19.43N/A
N/A
MFS Total Return I
EQNCX22.13N/A
N/A
MFS Equity Income C
NWZNX20.43N/A
N/A
Nationwide Loomis All Cap Gr Instl Svc
FSEBX13.50N/A
N/A
Fidelity Sustainable U.S. Equity Fund

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with BDX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then BDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+0.62%
BDX - SRDX
39%
Loosely correlated
-0.54%
TFX - SRDX
37%
Loosely correlated
+0.36%
ALGN - SRDX
29%
Poorly correlated
+0.62%
UFPT - SRDX
28%
Poorly correlated
+0.21%
SYK - SRDX
27%
Poorly correlated
-0.47%
More

VNRX and

Correlation & Price change

A.I.dvisor tells us that VNRX and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
+14.21%
STRRP - VNRX
27%
Poorly correlated
-0.56%
SRDX - VNRX
25%
Poorly correlated
+0.62%
VAPO - VNRX
25%
Poorly correlated
N/A
TLSI - VNRX
24%
Poorly correlated
-2.69%
RMD - VNRX
23%
Poorly correlated
-0.66%
More